Saad says SA’s biggest pharmaceutical manufacturer is still on the hunt for a potential European commercial partnerSA’s biggest pharmaceutical manufacturer Aspen Pharmacare says it is on track to meet its debt reduction targets by the end of its financial year, after agreeing to sell its Japanese business to Novartis’s generic division Sandoz for as much as €400m .
It has also entered into a five-year manufacturing and supply agreement with Sandoz for the portfolio of divested brands.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.
Loans Loans Latest News, Loans Loans Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aspen Pharmacare agrees to sell Japanese unitAspen has been disposing of assets to bring down debt, and want to sell its Japanese operations to Sandoz, a division of Switzerland-based Novartis
Source: BDliveSA - 🏆 12. / 63 Read more »
Aspen Pharmacare agrees to sell Japanese unitAspen has been disposing of assets to bring down debt, and want to sell its Japanese operations to Sandoz, a division of Switzerland-based Novartis
Source: BDliveSA - 🏆 12. / 63 Read more »